Identifying subgroup markers in heterogeneous populations

Nucleic Acids Research

Volumn 41, Issue 21, 2013, Pages

  De Ronde, Jorma J ^a   Rigaill, Guillem ^a   Rottenberg, Sven ^a   Rodenhuis, Sjoerd ^a   Wessels, Lodewyk F A ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DETECTION OF IMBALANCED DIFFERENTIAL SIGNAL; GENE EXPRESSION; GENETIC HETEROGENEITY; GENETIC MARKER; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; INTERMETHOD COMPARISON; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE DATABASE; REPORTER GENE; TREATMENT RESPONSE;

ALGORITHMS; ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84890022364     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt845     Document Type: Article

References (14)

1. Borst, P. and Wessels, L. (2010) Do predictive signatures really predict response to cancer chemotherapy? Cell Cycle, 9, 4836-4840.
2. Popovici, V., Chen, W., Gallas, B.G., Hatzis, C., Shi, W., Samuelson, F.W., Nikolsky, Y., Tsyganova, M., Ishkin, A., Nikolskaya, T. et al. (2010) Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. Breast Cancer Res., 12, R5.
3. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
4. de Ronde, J.J., Hannemann, J., Halfwerk, H., Mulder, L., Straver, M.E., Vrancken Peeters, M.J., Wesseling, J., van de Vijver, M., Wessels, L.F. and Rodenhuis, S. (2010) Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response. Breast Cancer Res. Treat, 119, 119-126.
5. Rodrigues, A.S., Dinis, J., Gromicho, M., Martins, C., Laires, A. and Rueff, J. (2012) Genomics and cancer drug resistance. Curr. Pharm. Biotechnol., 13, 651-673.
6. Rottenberg, S., Vollebergh, M.A., de Hoon, B., de Ronde, J., Schouten, P.C., Kersbergen, A., Zander, S.A., Pajic, M., Jaspers, J.E., Jonkers, M. et al. (2012) Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors. Cancer Res., 72, 2350-2361.
7. MacDonald, J.W. and Ghosh, D. (2006) COPA-cancer outlier profile analysis. Bioinformatics, 22, 2950-2951.
8. Tomlins, S.A., Rhodes, D.R., Perner, S., Dhanasekaran, S.M., Mehra, R., Sun, X.W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R. et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310, 644-648.
9. Tibshirani, R. and Hastie, T. (2007) Outlier sums for differential gene expression analysis. Biostatistics, 8, 2-8.
10. Wu, B. (2007) Cancer outlier differential gene expression detection. Biostatistics, 8, 566-575.
11. Lian, H. (2008) MOST: detecting cancer differential gene expression. Biostatistics, 9, 411-418.
12. Dekker, T.J., Borg, S.T., Hooijer, G.K., Meijer, S.L., Wesseling, J., Boers, J.E., Schuuring, E., Bart, J., van Gorp, J., Mesker, W.E. et al. (2012) Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach. Breast Cancer Res. Treat, 14, R93.
13. Huang, D.W., Sherman, B.T. and Lempicki, R.A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
14. Andersson, D.I. and Hughes, D. (2012) Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist. Updat., 15, 162-172.